US Stock MarketDetailed Quotes

ABOS Acumen Pharmaceuticals

Watchlist
  • 2.500
  • +0.050+2.04%
Close Oct 2 16:00 ET
  • 2.650
  • +0.150+6.01%
Post 17:38 ET
150.20MMarket Cap-2252P/E (TTM)

Acumen Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
80.89%24.38M
35.32%17.77M
35.15%61.14M
29.74%18.49M
41.05%16.04M
29.46%13.48M
42.68%13.14M
130.99%45.24M
69.32%14.25M
188.97%11.37M
Selling and administrative expenses
11.58%4.85M
20.42%5.33M
46.16%18.82M
48.29%5.19M
58.72%4.86M
40.61%4.35M
37.29%4.42M
76.89%12.88M
27.72%3.5M
43.42%3.06M
-General and administrative expense
11.58%4.85M
20.42%5.33M
46.16%18.82M
48.29%5.19M
58.72%4.86M
40.61%4.35M
37.29%4.42M
76.89%12.88M
27.72%3.5M
43.42%3.06M
Research and development costs
113.87%19.53M
42.88%12.45M
30.77%42.32M
23.70%13.29M
34.54%11.18M
24.75%9.13M
45.58%8.71M
162.99%32.36M
89.42%10.75M
361.61%8.31M
Operating profit
-80.89%-24.38M
-35.32%-17.77M
-35.15%-61.14M
-29.74%-18.49M
-41.05%-16.04M
-29.46%-13.48M
-42.68%-13.14M
-130.99%-45.24M
-69.32%-14.25M
-188.97%-11.37M
Net non-operating interest income expense
49.26%2.81M
64.03%3.01M
326.84%10.21M
142.10%3.37M
371.19%3.12M
624.62%1.88M
2,310.53%1.83M
2,747.62%2.39M
2,145.16%1.39M
4,635.71%663K
Non-operating interest income
102.55%3.82M
118.61%4.01M
351.13%10.79M
183.84%3.95M
371.19%3.12M
624.62%1.88M
2,310.53%1.83M
2,747.62%2.39M
2,145.16%1.39M
4,635.71%663K
Non-operating interest expense
--1M
--1M
--581K
----
----
--0
--0
--0
----
----
Other net income (expense)
6,550.00%1.03M
-2,500.00%-104K
-13,018.18%-1.44M
-13,710.00%-1.38M
-2,000.00%-42K
-16K
-500.00%-4K
99.99%-11K
-350.00%-10K
-110.53%-2K
Gain on sale of security
--1.1M
---50K
---1.36M
----
----
----
----
----
----
----
Other non- operating income (expenses)
-325.00%-68K
-1,250.00%-54K
-654.55%-83K
-110.00%-21K
-2,000.00%-42K
---16K
-500.00%-4K
-121.57%-11K
-350.00%-10K
-110.53%-2K
Income before tax
-76.89%-20.54M
-31.54%-14.87M
-22.20%-52.37M
-28.22%-16.5M
-20.98%-12.96M
-14.37%-11.61M
-23.86%-11.31M
57.40%-42.86M
-54.10%-12.87M
-174.47%-10.71M
Income tax
Net income
-76.89%-20.54M
-31.54%-14.87M
-22.20%-52.37M
-28.22%-16.5M
-20.98%-12.96M
-14.37%-11.61M
-23.86%-11.31M
57.40%-42.86M
-54.10%-12.87M
-174.47%-10.71M
Net income continuous Operations
-76.89%-20.54M
-31.54%-14.87M
-22.20%-52.37M
-28.22%-16.5M
-20.98%-12.96M
-14.37%-11.61M
-23.86%-11.31M
57.40%-42.86M
-54.10%-12.87M
-174.47%-10.71M
Minority interest income
Net income attributable to the parent company
-76.89%-20.54M
-31.54%-14.87M
-22.20%-52.37M
-28.22%-16.5M
-20.98%-12.96M
-14.37%-11.61M
-23.86%-11.31M
57.40%-42.86M
-54.10%-12.87M
-174.47%-10.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-76.89%-20.54M
-31.54%-14.87M
-22.20%-52.37M
-28.22%-16.5M
-20.98%-12.96M
-14.37%-11.61M
-23.86%-11.31M
57.40%-42.86M
-54.10%-12.87M
-174.47%-10.71M
Basic earnings per share
-21.43%-0.34
10.71%-0.25
-1.89%-1.08
9.38%-0.29
7.69%-0.24
-12.00%-0.28
-21.74%-0.28
78.88%-1.06
-55.13%-0.32
-160.00%-0.26
Diluted earnings per share
-21.43%-0.34
10.71%-0.25
-1.89%-1.08
9.38%-0.29
7.69%-0.24
-12.00%-0.28
-21.74%-0.28
78.88%-1.06
-55.13%-0.32
-160.00%-0.26
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 80.89%24.38M35.32%17.77M35.15%61.14M29.74%18.49M41.05%16.04M29.46%13.48M42.68%13.14M130.99%45.24M69.32%14.25M188.97%11.37M
Selling and administrative expenses 11.58%4.85M20.42%5.33M46.16%18.82M48.29%5.19M58.72%4.86M40.61%4.35M37.29%4.42M76.89%12.88M27.72%3.5M43.42%3.06M
-General and administrative expense 11.58%4.85M20.42%5.33M46.16%18.82M48.29%5.19M58.72%4.86M40.61%4.35M37.29%4.42M76.89%12.88M27.72%3.5M43.42%3.06M
Research and development costs 113.87%19.53M42.88%12.45M30.77%42.32M23.70%13.29M34.54%11.18M24.75%9.13M45.58%8.71M162.99%32.36M89.42%10.75M361.61%8.31M
Operating profit -80.89%-24.38M-35.32%-17.77M-35.15%-61.14M-29.74%-18.49M-41.05%-16.04M-29.46%-13.48M-42.68%-13.14M-130.99%-45.24M-69.32%-14.25M-188.97%-11.37M
Net non-operating interest income expense 49.26%2.81M64.03%3.01M326.84%10.21M142.10%3.37M371.19%3.12M624.62%1.88M2,310.53%1.83M2,747.62%2.39M2,145.16%1.39M4,635.71%663K
Non-operating interest income 102.55%3.82M118.61%4.01M351.13%10.79M183.84%3.95M371.19%3.12M624.62%1.88M2,310.53%1.83M2,747.62%2.39M2,145.16%1.39M4,635.71%663K
Non-operating interest expense --1M--1M--581K----------0--0--0--------
Other net income (expense) 6,550.00%1.03M-2,500.00%-104K-13,018.18%-1.44M-13,710.00%-1.38M-2,000.00%-42K-16K-500.00%-4K99.99%-11K-350.00%-10K-110.53%-2K
Gain on sale of security --1.1M---50K---1.36M----------------------------
Other non- operating income (expenses) -325.00%-68K-1,250.00%-54K-654.55%-83K-110.00%-21K-2,000.00%-42K---16K-500.00%-4K-121.57%-11K-350.00%-10K-110.53%-2K
Income before tax -76.89%-20.54M-31.54%-14.87M-22.20%-52.37M-28.22%-16.5M-20.98%-12.96M-14.37%-11.61M-23.86%-11.31M57.40%-42.86M-54.10%-12.87M-174.47%-10.71M
Income tax
Net income -76.89%-20.54M-31.54%-14.87M-22.20%-52.37M-28.22%-16.5M-20.98%-12.96M-14.37%-11.61M-23.86%-11.31M57.40%-42.86M-54.10%-12.87M-174.47%-10.71M
Net income continuous Operations -76.89%-20.54M-31.54%-14.87M-22.20%-52.37M-28.22%-16.5M-20.98%-12.96M-14.37%-11.61M-23.86%-11.31M57.40%-42.86M-54.10%-12.87M-174.47%-10.71M
Minority interest income
Net income attributable to the parent company -76.89%-20.54M-31.54%-14.87M-22.20%-52.37M-28.22%-16.5M-20.98%-12.96M-14.37%-11.61M-23.86%-11.31M57.40%-42.86M-54.10%-12.87M-174.47%-10.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -76.89%-20.54M-31.54%-14.87M-22.20%-52.37M-28.22%-16.5M-20.98%-12.96M-14.37%-11.61M-23.86%-11.31M57.40%-42.86M-54.10%-12.87M-174.47%-10.71M
Basic earnings per share -21.43%-0.3410.71%-0.25-1.89%-1.089.38%-0.297.69%-0.24-12.00%-0.28-21.74%-0.2878.88%-1.06-55.13%-0.32-160.00%-0.26
Diluted earnings per share -21.43%-0.3410.71%-0.25-1.89%-1.089.38%-0.297.69%-0.24-12.00%-0.28-21.74%-0.2878.88%-1.06-55.13%-0.32-160.00%-0.26
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data